CD8 + T cells from C57BL/6(B6) mice show cytotoxicity to B cell blasts prepared from syngeneic transgenic mice expressing HLA-DQ6 molecules in a mouse MHC class I H-2D b restricted manner. Althotigh these results suggest that CD8 + T cells recognize peptides derived from DQ6 molecule bound to H-2D b on target cells, no direct evidence so far has been obtained. To clarify this, we synthesized 23 peptides corresponding to DQ6a or/3 chain and carrying the motifs of Db-binding peptides, and examined their capacity to induce cytotoxicity in the CD8 + T cell line. We show here that DQAI-2, one of these peptides, induced cytotoxicity of the CD8 + T cells when this peptide was pulsed to H-2D b expressing target cells, as efficiently as HLA-DQ6 expressing target cells did. Thus, our results suggest that DQA 1-2 can be naturally processed from DQ6 molecules and recognized by the CD8 ÷ T cells in the context of H-2D b molecules. These results suggest that allogeneic HLA class II molecules are involved in the rejection not only as the ligand for T cell receptor of alloreactive CD4 + T cells but also as self-peptides bound to HLA class I molecules recognized by CD8 + T cells.
INTRODUCTION
The HLA rnultigene family consists of HLA class I and class II genes with extremely high polymorphism, and plays a central role in immune response through the presentation of antigenic peptides to CD8 + or CD4 + T cells, respectively. So far many studies have revealed that certain HLA-haplotypes are associat-ed with immune response to natural antigens (Sasazuki et aL, 1983; Sasazuki, 1990 ) and predisposition to autoimmune disease (Todd et aL, 1988) . It is also well established that HLA matching have a profound effect in the success of the organ transplantation (Thomas et aL, 1975; Beatty et al., 1985) . The strong linkage disequilibria between HLA alleles, however, precludes analyzing the role of individual HLA molecule in immune regulation and immune related disorder. To overcome this problem, we developed several lines of transgenic mice expressing either HLA-DR or DQ molecules (Nishimura et aL, 1990; Fukui et aL, 1993a, b; Yamamoto et alo, 1994) .
We have previously reported that HLA-DQ6 molecules expressed in transgenic mice function as appropriate MHC class II to mount immune response to the natural antigen and the antigenic peptide (Nishimura et al., 1990; Esaki et aL, 1994; Yamamoto et al., 1994) . However, we found that CD8 + T cells with cytotoxicity to DQ6-expressing B cell blasts were generated when syngeneic non-transgenic T cells were cultured with the transgenic spleen cells in vitro. Since this cytotoxicity is blocked by the monoclonal antibody (mAb) specific for mouse MHC class I H-2D b molecules, it was suggested that CD8 + T cells recognized DQ6-derived peptide in the context of H-2D b molecules (Inamitsu et al., 1992) . To clarify this possibility, we have tried the identification of DQ6-derived peptide which elicit cytotoxicity of the CD8 + T cells in the present study.
MATERIALS AND METHODS
Mice. The establishment of HLA-DQ6 transgenic mice have been previously reported (Nishimura et aL, 1990) . Briefly, transgenic mice were obtained by introducing genomic HLA-DQ6 A and B genes into fertilized eggs from C57BL/ 6(B6).
Peptides. All peptides were synthesized using the peptide synthesizer (Millipore Peptide Synthesizer 9050 Plus) and purified by HPLC.
Antibodies. Anti-HLA-DQ(4+5+6) mAb, HU-11, was a gift of Dr. A. Wakisaka, Hokkaido University, Sapporo, Japan. Anti-mouse CD4 mAb GK1.5 was obtained from American Type Culture Collection, Rockville, MD. Anti-IAb, kmAb (Meiji, Odawara, Japan), anti-mouse IgG coating magnetic beads, antirat IgG coating magnetic beads (Dynat A.S, Oslo, Norway) were used for establishment of DQ6-specific CD8 + T cell line. Fluorescein isothiocyanate-conjugated anti-HLA-DQ mAb, phycoerythrin-conjugated anti-CD4 mAb and fluorescein isothiocyanate-conjugated anti-CD8 mAb (Becton Dickinson, Mountain View, CA) were used for flow cytometric analysis.
Generation of the DQ6-specific CD8 + T cell line. B6 mice were immunized with irradiated DQ6 transgenic mice spleen cells (2× 10 ~) into the tail base and foot pads. Two weeks later, immunized mice were boosted with irradiated DQ6 spleen cells. Seven days later, lymph nodes were prepared and treated with anti-I-A b mAb and anti-mouse IgG coating magnetic beads to remove B cells. Purified T cells were stimulated several times with irradiated DQ spleen cells, and DQ6-specific CD8 + T cell lines (>95% CD8 + purified) were established by removing CD4 + T cells with rat anti-mouse CD4 mAb (GK1.5) and goat anti-rat IgG coating magnetic beads.
CTL assays. Spleen cells from B6 and DQ6-transgenic mice were treated by lipopolysaccharides (LPS) and used as target cells. 5ZCr-pulsed target cells (I × 104) were cultured with a various number of effector cells in a final volume of 200/zl of medium with or without peptides in 96-well round-bottom plate, and incubated for 4 hr at 37°C in 5% COz. In some experiments, mAbs specific to mouse MHC class I were added to the culture. Plate was centrifuged and radioactivity in 100/zl of supernatant were counted using a gamma counter. Percent specific lysis was
calculated as follows: (E-S)/(M-S)×
100 where E, S, M indicate the ~lCr release in the presence of cytolytic T lymphocytes (CTL), slCr release in the absence of CTL, 5~Cr release in the presence of 0.1% NP40, respectively.
RESULTS

Selection of DQ6-derived peptides with binding motifs to H-2D b molecules
The peptide motif binding to mouse class I molecules have been reported (Falk et alo, 1991) . According to this, H-2D b molecule specifically binds 9 to I1 amino acid length peptides which preferentially encode asparagin at position 5 and methionine at position 9. To identify peptide recognized by the DQ6-specific CD8 + T cell line in the context of D b molecules, we synthesized 23 candidate peptides corresponding to amino acid sequence of DQ6 a or/5' chains (DQA1-0103, which have asparagin at position 5 and/or methionine at position 9. The amino acid sequence of these 23 peptides are shown in Table 1 .
CTL assay using DQ6-derived peptides
B cell blasts prepared from B6 were pulsed with 23 synthesized peptides and the cytotoxicity of CD8 + T cells was examined (Fig. 1) . When the peptide DQAI-2 (SCGVNLYQF) was pulsed, definite cytotoxic activity of the CD8 + T cells was observed. This cytotoxicity did not result from the peptide toxicity to cells, because the DQA1-2 did not induce any cytotoxicity in the absence of DQ6-specific CD8 + T cell (Fig. 2) . Since this peptide induce the cytotoxicity of another DQ6 specifc CD8 + T cell line (ira-5) and is only the peptide to elicit the cytotoxicity (Fig. 3) , we conclude that "SCGVNLYQF" is the peptide recognized by DQ6-specific CD8 + T cells.
The cytotoxic activity induced by DQA I-2 was inhibited by Db-specific mAb, but not by Kb-specific mAb and DQ-specific mAb (Table 2) . Thus, these results indicate that DQ6-specific T cells recognized DQA1-2 in the context of D b molecule. 
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The cytotoxicity of the CD8 + T cell line (im-DQ) in the presence of DQ6-derived peptides. The middle parts of figure shows the cytotoxicity of the CD8 + T cells (im-DQ) when B6 target cells were pulsed with peptides DQA1-(1 to 11) and DQBI-(1 to 12) respectively at final concentration of 10/zg/ml. The left part of the figure shows the cytotoxicity when B cell blasts from B6 or HLA-DQ6 transgenic mice (DQ-B6) were used as target cells without peptides. 
DISCUSSION
Clinical studies have revealed that the matching of HLA class II alleles affects the success of organ transplantation as class I do (Beatty et aL, t985; Festenstein et al., 1986) . Murine allograft studies have also shown that difference in class II haplotype induce graft rejection (de Waal et al., 1983; Rosenberg et al., 1986) . 4 The cytotoxicity to indicated target cells of the CD8 ÷ T cells was examined with or without 200 fold diluted ascites form of Kb-specific mAb, Db-specific mAb or DQ-specific mAb (Hu-11).
% Inhibition was calculated by the formula; % Inhibition= [I--(% Specifc lysis with mAb/ % Specific lysis without mAb)] × 100.
Regarding the effect of MHC class II molecules on the rejection, two possibilities may be raised. First, CD4 + or CD8 + T cells might directly recognize allogeneic class II molecules, resulting in the graft rejection (Swain, 1983; Golding et al., 1987) . Second, cytotoxic CD8 + T cells which recognize class II-derived peptide bound to class. I molecules might play a crucial role in the graft rejection as was suggested by Shinohara et al. (1986) .
It is well established that exogenous antigens are processed into peptides in antigen presenting cells and mainly presented by class II molecules, whereas endogenous antigen are processed into peptides and mainly presented by class I molecules. We have previously shown that HLA-DQ6 molecules are recognized by mouse CD8 + T cells with the restriction of MHC class I, H-2D b molecules (Inamitsu et al., 1992) , suggesting that DQ6-derived peptide bound to H-2D b molecules are recognized by the CD8 + T cells. Supporting this, elution studies of MHC class I binding peptides have suggested that many peptides derived from MHC class I and class II molecules are bound to MHC class I molecules (Falk et al., 1990 (Falk et al., , 1991 . In the present study, we have identified the DQoe chain-derived peptide (SCGVNLYQF) which elicits the cytotoxicity of the CD8 + T cells by testing 23 peptides corresponding to DQa or DQfl chains with H-2D b binding motifs. Our results strongly suggest that '°SCGVNLYQF" is processed in antigen presenting cells and is recognized by CD8 + T cells in the context of H-2D b molecules.
Our results thus imply that the difference in HLA class II alleles between donors and recipients, in association with the particular HLA-class I molecules, have a profound negative effect on the success of the organ transplantation in humans via induction of cytotoxic CD8 + T cells which recognize HLA class II-derived peptide bound to HLA class I molecules. It is possible that HLA class I molecules and class II molecules encoded for by the genes on different chromosome of the donor generate the particular HLA class II-derived peptide bound to HLA class I molecules and are involved in the cytotoxic CD8 + T cell induction. In this point of view, further experiments should be done in a greater detail for the organ transplantation with the disparate HLA class II but the shared HLA class I molecules.
